ARTICLE | Clinical News
Misoprostol vaginal insert regulatory update
October 29, 2012 7:00 AM UTC
FDA accepted for review an NDA from Ferring for misoprostol vaginal insert (MVI) to decrease the time to vaginal delivery in women undergoing labor with an unfavorable cervix when used in sequential r...